Agnieska K. Witkiewicz

Suggest Changes
Learn More
TPS170 Background: Inhibitors of Poly(ADP-ribose) polymerase (PARP) are potent sensitizing agents for DNA-damaging chemotherapeutic agents such as the platinum analogs. The sensitizing effects of(More)
e14628 Background: Erlotinib proved to be active in unselected patients with metastatic PDA. Hence, there is an unmet need to select patients likely to respond to anti-EGFR therapy. IGF-1R was(More)
Hepatocellular carcinoma (HCC) is a significant worldwide health concern that is associated with discrete etiological events, encompassing viral infection, metabolic stress and genotoxic compounds.(More)
  • 1